What they were paid
Acumen Pharmaceuticals Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $77,935 | $13,696 | $15,415 | — | $107,046 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Acumen Pharmaceuticals, Inc. DEF 14A filed April 23, 2026, accession 0001628280-26-026870, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Acumen Pharmaceuticals pays directors a $40,000 cash retainer.
Committees
FY2025 · as the proxy prints themAudit · Compensation
The rest of the Acumen Pharmaceuticals board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Daniel O'Connell | Director | $0 |
| Derrell Porter | Independent Director | $73,111 |
| George Golumbeski | Chair of the Board | $82,742 |
| Jeffrey L. Ives | Independent Director | $79,111 |
| Kimberlee C. Drapkin | Independent Director | $89,111 |
| Laura Stoppel | Independent Director | $84,611 |
| Nathan B. Fountain | Independent Director | $73,111 |
The full Acumen Pharmaceuticals compensation record
free company briefThis page is one director within Acumen Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat